M. G. Rosenblum

Tumor necrosis factor alpha: a multifaceted peptide hormone.

M. G. Rosenblum, Nicholas J. Donato · PubMed · 1989 · 114 citations

Life Sciences, Cancer Biology, Immunology +12

Phase I trial of a 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers.

C. Frederick LeMaistre, Fiona E. Craig, C Meneghetti et al. · PubMed · 1993 · 90 citations

Medicine, Oncology, Pharmacology +17

Interferon-Induced Changes in Pharmacokinetics and Tumor Uptake of 111In-Labeled Antimelanoma Antibody 96.5 in Melanoma Patients

M. G. Rosenblum, L. Lamki, James L. Murray et al. · JNCI Journal of the National Cancer Institute · 1988 · 70 citations

Medicine, Oncology, Pharmacology +16

Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.

M. G. Rosenblum, Claire F. Verschraegen, James L. Murray et al. · PubMed · 1999 · 52 citations

Medicine, Oncology, Pharmacology +12

Design optimization and characterization of Her2/neu-targeted immunotoxins: comparative in vitro and in vivo efficacy studies

Yabing Cao, John W. Marks, Zhigang Liu et al. · Oncogene · 2013 · 46 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13